Phase 3 trial in 78 adults with acute central retinal artery occlusion: IV tenecteplase within 4.5 h did not improve 30-day vision recovery vs oral aspirin (20% vs 24%), with more adverse events including one fatal intracranial haemorrhage.
RCTn = 78
Ryan et al. A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion